GlassScriptPhysician profile
Allison Mink Barrow
NPI 1184266140
$7,644.66
in general payments reported to CMS, 2019-2025
20 companies · $2,156 in 2025
The $2,156 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,075 · 2022: $1,096 · 2023: $1,615 · 2024: $1,703 · 2025: $2,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,473.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $3,309.82 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $1,893.63 | 2021-2025 | Yeztugo, Descovy, Biktarvy |
| Abbvie INC. | $651.05 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $414.59 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Antares Pharma, INC. | $371.07 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Alkermes, INC. | $269.23 | 2022-2025 | Vivitrol, Vivitrol |
| Exact Sciences Corporation | $139.40 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Organon LLC | $138.23 | 2022-2024 | Nexplanon |
| Novo Nordisk INC | $83.72 | 2025 | |
| Indivior INC. | $55.37 | 2024-2025 | Sublocade |
| Dynavax Technologies Corporation | $48.57 | 2025 | Heplisav-B |
| Theratechnologies INC. | $47.20 | 2024 | Egrifta Sv, Egrifta, Trogarzo |
| Halozyme INC | $38.95 | 2023 | |
| Lilly USA, LLC | $35.62 | 2021 | |
| Verity Pharmaceuticals INC. | $33.85 | 2024-2025 | Tlando |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $30.00 | 2024 | Voquezna |
| Ibsa Pharma INC. | $23.23 | 2025 | Tirosint, Flector, Licart |
| Hologic Sales and Service, LLC | $22.00 | 2023 | Aptima, Thinprep 2000 Processor |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.89 | 2023 | |
| Janssen Biotech, INC. | $17.24 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Barrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.